Abraham Ceesay

Chief Executive Officer, Director, Rapport Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$6.0M

Companies

Latest trade

Oct 21, 2026

Companies

Rapport Therapeutics, Inc.Chief Executive Officer, Director −$6.3M

Trades

RAPP Sold 2,210 shares at $29.16 · planned $0.1M Oct 21

RAPP Sold 1,147 shares at $30.66 · planned $0.0M Oct 7

RAPP Sold 3,375 shares at $32.03 · planned $0.1M Oct 6

RAPP Sold 2,210 shares at $39.17 · planned $0.1M Sep 23

RAPP Sold 8,210 shares at $45.62 · planned $0.4M Sep 8

RAPP Sold 18,921 shares at $49.57 · planned $0.9M Aug 25

RAPP Sold 28,958 shares at $48.01 · planned $1.4M Aug 11

RAPP Sold 22,541 shares at $46.26 · planned $1.0M Aug 10

RAPP Sold 2,210 shares at $42.11 · planned $0.1M Jul 27

RAPP Sold 8,210 shares at $40.00 · planned $0.3M Jul 14

RAPP Sold 8,220 shares at $39.83 · planned $0.3M Jun 29

RAPP Sold 10,916 shares at $29.35 · planned $0.3M Feb 18

RAPP Sold 10,916 shares at $26.12 · planned $0.3M Jan 20

RAPP Sold 10,916 shares at $29.64 · planned $0.3M Dec 17

RAPP Sold 10,916 shares at $25.20 · planned $0.3M Nov 17

RAPP Sold 10,916 shares at $25.81 · planned $0.3M Oct 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.